TADFX
Price
$10.07
Change
+$0.13 (+1.31%)
Updated
Jun 2 closing price
Net Assets
216.24M
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

TADFX vs VIVIX

Header iconTADFX vs VIVIX Comparison
Open Charts TADFX vs VIVIXBanner chart's image
TADFX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
TADFX vs. VIVIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TADFX is a Hold and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. TADFX (216M). VIVIX pays higher dividends than TADFX: VIVIX (1.87) vs TADFX (1.26). TADFX was incepted earlier than VIVIX: TADFX (11 years) vs VIVIX (28 years). TADFX (0.77) is less costly to investors than VIVIX (0.03). TADFX is a more actively managed with annual turnover of: 22.00 vs. VIVIX (8.00). TADFX has a lower initial minimum investment than VIVIX: TADFX (0) vs VIVIX (5000000). TADFX (23.63) and VIVIX (23.24) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.71 vs. TADFX (16.61).
TADFXVIVIXTADFX / VIVIX
Total Expense Ratio0.770.032,567%
Annual Report Gross Expense Ratio0.770.032,567%
Fund Existence11 years28 years-
Gain YTD14.89810.670140%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets216M238B0%
Annual Yield % from dividends1.261.8767%
Returns for 1 year23.6323.24102%
Returns for 3 years50.5753.1895%
Returns for 5 years16.6150.7133%
Returns for 10 years-1.42150.42-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAZEX21.980.08
+0.37%
Oakmark International Small Cap R6
SGIIX88.030.09
+0.10%
First Eagle Global I
FRIFX12.52N/A
N/A
Fidelity Real Estate Income
BRTNX79.58N/A
N/A
Bretton Fund
ARRQX21.18N/A
N/A
Aristotle Value Equity R6